EMBO Molecular Medicine (Oct 2024)

Breast cancer secretes anti-ferroptotic MUFAs and depends on selenoprotein synthesis for metastasis

  • Tobias Ackermann,
  • Engy Shokry,
  • Ruhi Deshmukh,
  • Jayanthi Anand,
  • Laura C A Galbraith,
  • Louise Mitchell,
  • Giovanny Rodriguez-Blanco,
  • Victor H Villar,
  • Britt Amber Sterken,
  • Colin Nixon,
  • Sara Zanivan,
  • Karen Blyth,
  • David Sumpton,
  • Saverio Tardito

DOI
https://doi.org/10.1038/s44321-024-00142-x
Journal volume & issue
Vol. 16, no. 11
pp. 2749 – 2774

Abstract

Read online

Abstract The limited availability of therapeutic options for patients with triple-negative breast cancer (TNBC) contributes to the high rate of metastatic recurrence and poor prognosis. Ferroptosis is a type of cell death caused by iron-dependent lipid peroxidation and counteracted by the antioxidant activity of the selenoprotein GPX4. Here, we show that TNBC cells secrete an anti-ferroptotic factor in the extracellular environment when cultured at high cell densities but are primed to ferroptosis when forming colonies at low density. We found that secretion of the anti-ferroptotic factors, identified as monounsaturated fatty acid (MUFA) containing lipids, and the vulnerability to ferroptosis of single cells depends on the low expression of stearyl-CoA desaturase (SCD) that is proportional to cell density. Finally, we show that the inhibition of Sec-tRNAsec biosynthesis, an essential step for selenoprotein production, causes ferroptosis and impairs the lung seeding of circulating TNBC cells that are no longer protected by the MUFA-rich environment of the primary tumour.

Keywords